| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $123.7M | +63.5% |
| R&D Expense | $141.5M | +16.4% |
| SG&A Expense | $36.4M | +3.4% |
| Operating Income | -$54.2M | +33.2% |
| Pre-tax Income | -$39.7M | +43.4% |
| Income Tax | -$1.1M | -142.7% |
| Net Income | -$38.6M | +46.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $129.9M | -42.1% |
| Current Assets | $393.2M | +4.2% |
| Total Assets | $448.7M | +2.3% |
| Current Liabilities | $64.2M | -59.1% |
| Total Liabilities | $215.6M | -0.1% |
| Stockholders' Equity | $233.1M | +4.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.8M | -154.3% |
| Capital Expenditures | $4.7M | +17.9% |
| Investing Cash Flow | -$101.8M | -129.1% |
| Financing Cash Flow | $30.4M | -69.3% |
| Free Cash Flow | -$27.5M | -172.3% |